BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24236489)

  • 1. Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine.
    Spencer BW; Prainsack B; Rujescu D; Giegling I; Collier DA; Gaughran F; MacCabe JH; Barr CL; Sigurdsson E; Stovring H; Malhotra AK; Curran SR;
    Pharmacogenomics; 2013 Nov; 14(15):1907-14. PubMed ID: 24236489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.
    Sriretnakumar V; Huang E; Müller DJ
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1709-31. PubMed ID: 26364648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
    Masellis M; Basile VS; Ozdemir V; Meltzer HY; Macciardi FM; Kennedy JL
    Biol Psychiatry; 2000 Feb; 47(3):252-66. PubMed ID: 10682223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
    Citrome L; McEvoy JP; Saklad SR
    Clin Schizophr Relat Psychoses; 2016; 10(3):163-177. PubMed ID: 27732102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of alcohol intake in the pharmacogenetics of treatment with clozapine.
    Monroy-Jaramillo N; Martínez-Magaña JJ; Pérez-Aldana BE; Ortega-Vázquez A; Montalvo-Ortiz J; López-López M
    Pharmacogenomics; 2022 Apr; 23(6):371-392. PubMed ID: 35311547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
    Vasudev K; Choi YH; Norman R; Kim RB; Schwarz UI
    Can J Psychiatry; 2017 Feb; 62(2):138-149. PubMed ID: 27681143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of pharmacogenetics in a clozapine treatment resistant patient: a case report.
    Sangüesa E; Cirujeda C; Concha J; Padilla PP; Ribate MP; García CB
    Pharmacogenomics; 2019 Aug; 20(12):871-877. PubMed ID: 31453772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clozapine].
    Inada K; Ishigooka J
    Nihon Rinsho; 2013 Apr; 71(4):678-83. PubMed ID: 23678599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More than 25 years of genetic studies of clozapine-induced agranulocytosis.
    de With SAJ; Pulit SL; Staal WG; Kahn RS; Ophoff RA
    Pharmacogenomics J; 2017 Jul; 17(4):304-311. PubMed ID: 28418011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.
    Munro J; O'Sullivan D; Andrews C; Arana A; Mortimer A; Kerwin R
    Br J Psychiatry; 1999 Dec; 175():576-80. PubMed ID: 10789357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic testing in the clinical management of schizophrenia: a decision-analytic model.
    Perlis RH; Ganz DA; Avorn J; Schneeweiss S; Glynn RJ; Smoller JW; Wang PS
    J Clin Psychopharmacol; 2005 Oct; 25(5):427-34. PubMed ID: 16160617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clozapine in the treatment of under-age schizophrenia].
    Haapasalo-Pesu KM
    Duodecim; 2009; 125(15):1635-8. PubMed ID: 19769179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clozapine: the commitment to patient safety.
    Alphs LD; Anand R
    J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eosinophilic colitis caused by clozapine].
    de Raad AW; Siegersma NC; Clahsen PC; Hagestein-de Bruijn C
    Ned Tijdschr Geneeskd; 2011; 155(36):A3620. PubMed ID: 21914234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics in schizophrenia: the quest for individualized therapy.
    Basile VS; Masellis M; Potkin SG; Kennedy JL
    Hum Mol Genet; 2002 Oct; 11(20):2517-30. PubMed ID: 12351588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.
    Verbelen M; Collier DA; Cohen D; MacCabe JH; Lewis CM
    Pharmacogenomics J; 2015 Oct; 15(5):461-6. PubMed ID: 25732907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle.
    Basile VS; Masellis M; McIntyre RS; Meltzer HY; Lieberman JA; Kennedy JL
    J Clin Psychiatry; 2001; 62 Suppl 23():45-66. PubMed ID: 11603885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics in schizophrenia: a review of clozapine studies.
    Kohlrausch FB
    Braz J Psychiatry; 2013; 35(3):305-17. PubMed ID: 24142094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine-induced effuso-constrictive pericarditis. Case report and review of the literature.
    Rathore S; Masani ND; Callaghan PO
    Cardiology; 2007; 108(3):183-5. PubMed ID: 17085936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study.
    Lee J; Takeuchi H; Fervaha G; Powell V; Bhaloo A; Bies R; Remington G
    J Clin Psychopharmacol; 2015 Oct; 35(5):510-6. PubMed ID: 26267420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.